Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study

Article Type
Article
Changed
Thu, 01/10/2019 - 12:20
Display Headline
Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
Author(s)
Stough D
Bucko AD
Vamvakias G
Rafal ES
Davis SA

Article PDF
085050267.pdf
Author and Disclosure Information

Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA

Issue
Cutis - 85(5)
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Page Number
267-273
Sections
Original Research
Author(s)
Stough D
Bucko AD
Vamvakias G
Rafal ES
Davis SA
Author(s)
Stough D
Bucko AD
Vamvakias G
Rafal ES
Davis SA
Author and Disclosure Information

Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA

Author and Disclosure Information

Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA

Article PDF
085050267.pdf
Article PDF
085050267.pdf

Issue
Cutis - 85(5)
Issue
Cutis - 85(5)
Page Number
267-273
Page Number
267-273
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Article Type
Article
Display Headline
Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
Display Headline
Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis

Article Type
Article
Changed
Thu, 01/10/2019 - 11:57
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S

Article PDF
070060335.pdf
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Issue
Cutis - 70(6)
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Melanoma
Page Number
335-339
Sections
Original Research
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Article PDF
070060335.pdf
Article PDF
070060335.pdf

Issue
Cutis - 70(6)
Issue
Cutis - 70(6)
Page Number
335-339
Page Number
335-339
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Melanoma
Article Type
Article
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Davis SA